Rabbit Anti-GRASP1 Polyclonal Antibody, Unconjugated from Abcam
Porcine Galanin , 3-[125I]iodotyrosyl26 Conjugated/Tagged from GE Healthcare, formerly Amersham Biosciences
Rabbit Anti-CRIPT Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Rabbit Anti-HES1 Antibody, Unconjugated from ABR-Affinity BioReagents
Biology Products:(Date:11/24/2009)...le in Spanish . , The presence of increased...tory substances in the blood, hinders the loss and...h project of the University of Navarra conducted b...ool of Pharmacy. , The project, entitled "A nutr... control of body weight and inflammation," examine...
(Date:11/23/2009)...2009 - The time of day matters to forest trees dea...ed by a research team led by Professor Malcolm Cam...incipal for research and colleagues in the departm...campus. , Capitalizing on their previous work ...rch team examined how poplar trees use their 45,00...
(Date:11/23/2009)... study provides "incontrovertible evidence" that t...f Sumatra about 73,000 years ago deforested much o...er, researchers report. , The volcano ejected an...mosphere, leaving a crater (now the world,s larges...5 kilometers wide. Ash from the event has been fou...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2Time of day matters to thirsty trees, U of T researcher discovers 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Allied Worlds Susan Chmieleski to Participate in Hospital Management Asia 2009 Conference 54129 1Allied Worlds Susan Chmieleski to Participate in Hospital Management Asia 2009 Conference 54129 2Allied Worlds Susan Chmieleski to Participate in Hospital Management Asia 2009 Conference 54129 3APTA Calls For CMS and Congressional Action to Prohibit Unqualified Personnel From Providing Physical Therapy Services 54126 1APTA Calls For CMS and Congressional Action to Prohibit Unqualified Personnel From Providing Physical Therapy Services 54126 2APTA Calls For CMS and Congressional Action to Prohibit Unqualified Personnel From Providing Physical Therapy Services 54126 3PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 1PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 2PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 3PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 4PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 5PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 6PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 7PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 8PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 9PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 10PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 11PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 12PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 13PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 14PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 15PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 16PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 17(Date:11/24/2009)..., Iceland, November 24 d...ed the approval of all of its,"first day" motions ...elaware,(the "Bankruptcy Court"). deCODE last week...er 11 of the United States Bankruptcy Code with th...y the Bankruptcy Court allow the company to contin...
(Date:11/24/2009)... /PRNewswire-Asia/ -- Shanghai Biolaxy announced t...FDA) has approved the,investigational new drug app...n), an innovative insulin formulation to treat dia...e its first phase I clinical study. , Dia...lucose and poor,metabolism. The complications of d...
(Date:11/24/2009)...point has been met for patients with advanced-stag...EC CITY, Nov. 24 /PRNewswire-FirstCall/ - AEterna ...pany"), a global biopharmaceutical company focused...d positive efficacy data from a Phase 2 study with...8 (formerly AN-152), in patients with advanced or ...
(Date:11/24/2009)...09 Arena Pharmaceuticals... company is scheduled to present at the Piper Jaff... 1, 2009 at 11:30 a.m. Eastern Time (8:30 a.m. Pac...k City. Jack Lief, Arena,s President and Chief Exe...w of the company, including its clinical developme...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3